137988-24-0

Basic information

• Product Name: Benzoic acid, 4-(cyanomethoxy)-, methyl ester
• CAS NO: 137988-24-0
• Molecular Formula: C10H9NO3
• Molecular Weight: 191.186
• Mol File: 137988-24-0.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(cyanomethoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(cyanomethoxy)-, methyl ester(137988-24-0)
• EPA Substance Registry System: Benzoic acid, 4-(cyanomethoxy)-, methyl ester(137988-24-0)

Safety Data

• Hazardous Substances Data: 137988-24-0(Hazardous Substances Data)

Upstream product

• 107-14-2 chloroacetonitrile 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 99768-12-4 4-methoxycarbonylphenylboronic acid 
• 590-17-0 cyanomethyl bromide 

Downstream Products

• 243657-63-8 methyl 4-(2-oxo-2-(2,4,6-trihydroxyphenyl)ethoxy)benzoate 
• 1532534-63-6 methyl 4-(2-(2,4-dihydroxy-5-propylphenyl)-2-oxoethoxy)benzoate 
• 1532534-37-4 methyl 4-(2-(2,4-dihydroxy-5-methylphenyl)-2-oxoethoxy)benzoate 
• 137987-92-9 methyl 4-(2-(2,4-dihydroxyphenyl)-2-oxoethoxy)benzoate 
• 1532533-81-5 methyl 4-(2-(5-ethyl-2,4-dihydroxyphenyl)-2-oxoethoxy)benzoate 
• 728038-32-2 methyl 4-(2H-tetrazol-5-ylmethoxy)benzoate 
• 137988-21-7 4-(7-Acetoxy-4-oxo-4H-chromen-3-yloxy)-benzoic acid methyl ester 
• 137988-05-7 methyl-4[(7-hydroxy-4-oxo-4H-chromen-3-yl)oxy]benzoate 
• 243657-76-3 4-(5,7-diacetoxy-2-methyl-4-oxo-4H-chromen-3-yloxy)-benzoic acid methyl ester 
• 56850-93-2 methyl 4-(2-Aminoethyloxy)benzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 

Relevant articles and documents

Synthesis of aryloxyacetonitriles based on arylboronic acids with 2-bromoacetonitrile

A new and efficient protocol for the synthesis of aryloxyacetonitriles based on arylboronic acids with 2-bromoacetonitrile has been developed using eco-friendly hydrogen peroxide as oxidant under metal-free conditions. This method is compatible with arylboronic acid attached sensitive substituent and obtains desired product in moderate to good yield.

SUBSTITUTED 2-INDOLINONE AS PTK INHIBITORS CONTAINING A ZINC BINDING MOIETY

The present invention relates to substituted 2-indolinone containing zinc- binding moiety based derivatives that have enhanced or unique properties as inhibitors of protein tyrosine kinase (PTK) receptors and their use in the treatment of PTK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

PHARMACEUTICAL PREPARATIONS COMPRISING INSULIN, ZINC IONS AND A ZINC-BINDING LIGAND

Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes.